PUNJABCHEMPunjab Chemicals & Crop Protection Ltd.
Punjab Chemicals & Crop Protection Q2 FY27 Results: Consolidated Net Profit ₹13.46 Crore on Total Income of ₹329 Crore
- Earnings
- chemicals and crop protection
Reviewed byRachit TripathiBlacklitt Research
Punjab Chemicals & Crop Protection (NSE: PUNJABCHEM) reported consolidated total income of ₹329 crore and consolidated net profit of ₹13 crore for the quarter ended 30 Sep 2026, against standalone total income of ₹329 crore and standalone net profit of ₹14 crore, it said in a filing on 03 Nov 2026.
Key highlights
Consolidated
Including its subsidiaries
- Total income: ₹329 crore, up 26.0% YoY and 5.4% lower QoQ
- Net profit and EPS: ₹13 crore, down 27.4% YoY; basic EPS ₹10.98
- Finance costs: ₹6 crore, 1.8% of total income, up 50.0% YoY
Standalone
The company on its own, without its subsidiaries
- Total income: ₹329 crore, up 26.8% YoY and 5.2% lower QoQ
- Net profit and EPS: ₹14 crore, down 20.1% YoY; basic EPS ₹11.33
- Final dividend: ₹3.68 crore appropriated in the quarter for FY26, ₹3.00 per share
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 329 | 261 | +26.0% | 348 | -5.4% | |
| Revenue from operations | 327 | 255 | +28.0% | 347 | -5.9% |
| Other income | 2 | 6 | -60.7% | 1 | +251.5% |
| 13 | 19 | -27.4% | 22 | -39.0% | |
| Profit before tax | 18 | 22 | -16.4% | 30 | -39.2% |
| Finance costs | 6 | 4 | +50.0% | 4 | +38.0% |
| Depreciation | 8 | 7 | +20.0% | 7 | +9.0% |
| Tax expense | 5 | 3 | +44.2% | 8 | -39.5% |
| Net profit margin | 4.09% | 7.10% | -3.01 pp | 6.34% | -2.25 pp |
| EPS, basic (₹) | 10.98 | 15.12 | -27.4% | 18.00 | -39.0% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Income grew faster than profit. Total income rose 26.0% year on year, but net profit fell 27.4%. Revenue from operations rose 28.0%, while other income fell 60.7% to ₹2.39 crore, which is 13.1% of profit before tax of ₹18.29 crore.
Depreciation rose to ₹7.98 crore from ₹6.65 crore. Tax of ₹4.83 crore is 26.4% of profit before tax, against ₹3.35 crore in the year-earlier quarter.
The filing names a single operating segment, Performance Chemicals. The consolidated statement includes the wholly owned Belgian subsidiary SD Agchem (Europe) NV.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 329 | 260 | +26.8% | 347 | -5.2% | |
| Revenue from operations | 327 | 254 | +28.7% | 346 | -5.8% |
| Other income | 2 | 6 | -57.5% | 1 | +258.8% |
| 14 | 17 | -20.1% | 22 | -37.3% | |
| Profit before tax | 19 | 21 | -9.7% | 30 | -37.9% |
| Finance costs | 6 | 4 | +50.0% | 4 | +38.0% |
| Depreciation | 8 | 7 | +20.4% | 7 | +9.3% |
| Tax expense | 5 | 3 | +44.2% | 8 | -39.5% |
| Net profit margin | 4.22% | 6.70% | -2.48 pp | 6.38% | -2.16 pp |
| EPS, basic (₹) | 11.33 | 14.18 | -20.1% | 18.07 | -37.3% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone revenue from operations rose 28.7% year on year, while net profit fell 20.1%. Other income fell 57.5% to ₹2.44 crore, 13.0% of profit before tax of ₹18.72 crore.
Standalone trade receivables rose to ₹456.58 crore at 30 Sep 2026 from ₹203.63 crore at 31 Mar 2026. The filing does not give the reason for the increase. Standalone tax of ₹4.83 crore is 25.8% of profit before tax.
The year-ended statement shows an exceptional item, Impact of New Labour Codes, of ₹2.08 crore. The quarter shows no exceptional item.
Inference
The board approved the ₹3.68 crore final dividend for FY26, which was appropriated during the quarter, and approved remuneration for Managing Director Shalil Shashikumar Shroff for 15 Jan 2027 to 14 Jan 2029 and for non-executive director Shivshankar Shripal Tiwari, both subject to shareholder approval. It also approved cancelling 15,033 unsubscribed equity shares, subject to shareholder approval, and a Postal Ballot Notice on these matters.
The filing does not state the amount of either director's remuneration, the reason for cancelling the shares, or the reason for the rise in trade receivables.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
